Provided by Tiger Trade Technology Pte. Ltd.

Irhythm Technologies Inc.

128.52
+0.54000.42%
Post-market: 128.520.00000.00%19:30 EDT
Volume:451.64K
Turnover:57.94M
Market Cap:4.22B
PE:-299.11
High:129.66
Open:129.45
Low:125.73
Close:127.98
52wk High:212.00
52wk Low:100.85
Shares:32.85M
Float Shares:31.65M
Volume Ratio:0.73
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4297
EPS(LYR):-1.3920
ROE:-9.63%
ROA:0.65%
PB:22.70
PE(LYR):-92.32

Loading ...

iRhythm - on June 9, Receives Threat Actor Communications Claiming Access to Sensitive and Patient Data - SEC Filing

THOMSON REUTERS
·
Jun 16

iRhythm - No Evidence of Ongoing Unauthorized Access to iRhythm Systems - SEC Filing

THOMSON REUTERS
·
Jun 16

iRhythm - Determines Cybersecurity Incident Material on June 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 16

iRhythm - No Impact Identified to Products, Clinical Systems, Patient Safety, or Operations - SEC Filing

THOMSON REUTERS
·
Jun 16

iRhythm - Affected Data Obtained Through Social Engineering From Third-Party Applications - SEC Filing

THOMSON REUTERS
·
Jun 16

iRhythm reports data exfiltration from third-party business apps after cyber incident

Reuters
·
Jun 16

iRhythm Technologies Price Target Maintained With a $185.00/Share by BTIG

Dow Jones
·
Jun 10

A Look At iRhythm Holdings (IRTC) Valuation After Governance Changes And Lawsuit Settlement

Simply Wall St.
·
Jun 07

iRhythm Technologies Reaches $45 Million Securities Class Settlement

TIPRANKS
·
Jun 05

iRhythm Enters Binding Settlement Agreement To Resolve Class Action Securities Litigation - SEC Filing

Reuters
·
Jun 05

iRhythm - Enters Binding Settlement Agreement to Resolve Class Action Securities Litigation - SEC Filing

THOMSON REUTERS
·
Jun 05

iRhythm - Settlement Agreement Provides for $45 Mln Payment for Dismissal and Release of Claims - SEC Filing

THOMSON REUTERS
·
Jun 05

iRhythm - Settlement Agreement Not Expected to Impact Adj Ebitda, Net Income, or Operating Expenses - SEC Filing

THOMSON REUTERS
·
Jun 05

iRhythm agrees to $45 million settlement to resolve securities class action lawsuit

Reuters
·
Jun 05

Top Irhythm Executives Quietly Cash In With Fresh Stock Sales

TIPRANKS
·
Jun 04

Analyst Initiates Buy on iRhythm, Citing Long-Term Growth Drivers, FDA-Approved Algorithm and Attractive 2026 Valuation

TIPRANKS
·
Jun 03

iRhythm posts investor presentation outlining ambulatory cardiac monitoring growth strategy

Reuters
·
Jun 02

iRhythm Technologies Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jun 02

iRhythm price target lowered to $152 from $180 at Canaccord

TIPRANKS
·
Jun 01

iRhythm Technologies Inc : Canaccord Genuity Cuts Target Price to $152 From $180

THOMSON REUTERS
·
Jun 01